NCT06645977

Brief Summary

Prospective monocentric collection of data from adult patients with interstitial lung disease (ILD), to provide real-world data on current patient management at the ILD clinic.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 18, 2024

Completed
14 days until next milestone

Study Start

First participant enrolled

April 1, 2024

Completed
7 months until next milestone

First Posted

Study publicly available on registry

October 17, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 4, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 4, 2025

Completed
Last Updated

October 17, 2024

Status Verified

October 1, 2024

Enrollment Period

1 year

First QC Date

March 18, 2024

Last Update Submit

October 15, 2024

Conditions

Interstitial Lung Disease

Outcome Measures

Primary Outcomes (1)

  • Prevalce ILD

    5 years

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients diagnosed with interstitial lung disease from ILD clinic of the Fondazione Policlinico Universitario A. Gemelli IRCCS in Rome.

You may qualify if:

  • Age \>= 18 years
  • Diagnosis of ILD, according to international guidelines.

You may not qualify if:

  • Inability to give informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fondazione Policlinico Universitario Agostino Gemelli

Rome, RM, 00168, Italy

RECRUITING

MeSH Terms

Conditions

Lung Diseases, Interstitial

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract Diseases

Central Study Contacts

Luca Richeldi

CONTACT

0630157857luca.richeldi@policlinicogemelli.it

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

March 18, 2024

First Posted

October 17, 2024

Study Start

April 1, 2024

Primary Completion

April 4, 2025

Study Completion

April 4, 2025

Last Updated

October 17, 2024

Record last verified: 2024-10

Locations

IT(1)